person · Reporting owner

Wilson-Thompson Kathleen

Disclosed activity across 6 companies

Tapewire entity: 10899
SEC CIK: 0001331680

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ASHLAND INC.ASH · Entity 4139	Director	January 30, 2020	February 03, 2020
MCKESSON CORPMCK · Entity 2904	Director	July 22, 2026	July 23, 2026
Tesla, Inc.TSLA · Entity 2791	Director	April 30, 2026	May 04, 2026
Vulcan Materials COVMC · Entity 3118	Director	May 11, 2018	May 15, 2018
WOLVERINE WORLD WIDE INC /DE/WWW · Entity 1665	Director	May 07, 2026	May 11, 2026
Walgreens Boots Alliance, Inc.WBA · Entity 16467	EVP and Global Chief HRO	November 01, 2020	November 02, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ASHLAND INC.

Report date January 30, 2020 · Filed February 03, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	5,225	Reported balance After 2020-01-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2020-01-30 · Grant · Acquired 1,449 · Balance 5,225 F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3: Balance includes 12 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 14 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.

F2: Grant of stock-settled Restricted Stock Units granted under Ashland's Omnibus Incentive Plan and deferred under Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.)

F3: Balance includes 12 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2019, 13 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2019, and 14 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2019.

MCKESSON CORP

Report date July 22, 2026 · Filed July 23, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	578	Reported balance After 2026-07-22 transaction · row 1 1 source row Row 1 · 2026-07-22 · Grant · Acquired 277 · Balance 578 F1: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vested immediately, and the reporting person elected to receive the underlying shares upon grant.

Filing footnotes · ownership attribution and instrument terms

F1: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vested immediately, and the reporting person elected to receive the underlying shares upon grant.

Tesla, Inc.

Report date April 30, 2026 · Filed May 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	48,399	Ending reported balance After 2026-04-30 transaction · row 17 17 source rows · reconciled sequence Row 1 · 2026-04-30 · Exercise / conversion · Acquired 40,948 · Balance 74,808 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. Row 2 · 2026-04-30 · Sale · Disposed 840 · Balance 73,968 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.360 to $369.350, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-04-30 · Sale · Disposed 1,520 · Balance 72,448 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.360 to $370.320, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-04-30 · Sale · Disposed 1,275 · Balance 71,173 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $370.380 to $371.360, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-04-30 · Sale · Disposed 1,020 · Balance 70,153 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.380 to $372.370, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-04-30 · Sale · Disposed 619 · Balance 69,534 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.380 to $373.350, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-04-30 · Sale · Disposed 520 · Balance 69,014 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.910 to $374.870, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-04-30 · Sale · Disposed 280 · Balance 68,734 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.940 to $375.600, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-04-30 · Sale · Disposed 1,081 · Balance 67,653 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.000 to $376.970, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-04-30 · Sale · Disposed 3,003 · Balance 64,650 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $377.020 to $377.990, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-04-30 · Sale · Disposed 3,480 · Balance 61,170 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $378.050 to $379.040, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-04-30 · Sale · Disposed 1,760 · Balance 59,410 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.090 to $380.070, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-04-30 · Sale · Disposed 1,755 · Balance 57,655 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.130 to $381.120, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-04-30 · Sale · Disposed 6,896 · Balance 50,759 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.140 to $382.110, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-04-30 · Sale · Disposed 680 · Balance 50,079 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $382.140 to $382.800, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-04-30 · Sale · Disposed 1,240 · Balance 48,839 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $383.140 to $384.110, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-04-30 · Sale · Disposed 440 · Balance 48,399 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $384.150 to $384.660, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.99 · Expires 2026-06-18	Direct	0	Reported balance After 2026-04-30 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2026-04-30 · Exercise / conversion · Disposed 40,948 · Balance 0 F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. F18: 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from June 18, 2019, such that all shares subject to the option were fully vested and exercisable by June 18, 2022.

Filing footnotes · ownership attribution and instrument terms

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.360 to $369.350, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.360 to $370.320, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $370.380 to $371.360, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.380 to $372.370, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.380 to $373.350, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.910 to $374.870, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.940 to $375.600, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.000 to $376.970, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $377.020 to $377.990, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $378.050 to $379.040, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.090 to $380.070, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.130 to $381.120, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.140 to $382.110, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $382.140 to $382.800, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $383.140 to $384.110, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $384.150 to $384.660, inclusive. The reporting person undertakes to provide Tesla, Inc., any security holder of Tesla, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from June 18, 2019, such that all shares subject to the option were fully vested and exercisable by June 18, 2022.

Vulcan Materials CO

Report date May 11, 2018 · Filed May 15, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	15,780.89	Reported balance After 2018-05-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-05-11 · Grant · Acquired 1,180 · Balance 15,780.89 F1: Convertible on a 1-for-1 basis. F2: Annual deferred stock grant made to the reporting person under the Vulcan Materials Company 2016 Omnibus Long-Term Incentive Plan. F3: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan.

Filing footnotes · ownership attribution and instrument terms

F1: Convertible on a 1-for-1 basis.

F2: Annual deferred stock grant made to the reporting person under the Vulcan Materials Company 2016 Omnibus Long-Term Incentive Plan.

F3: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan.

WOLVERINE WORLD WIDE INC /DE/

Report date May 07, 2026 · Filed May 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	9,113	Reported balance After 2026-05-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-07 · Grant · Acquired 9,113 · Balance 9,113 F1: Converts into shares of Common Stock on a one-for-one basis. F2: The Restricted Stock Units vest on May 7, 2027; however, the Reporting Person has elected to defer receipt of the shares until May 7, 2031.

Filing footnotes · ownership attribution and instrument terms

F1: Converts into shares of Common Stock on a one-for-one basis.

F2: The Restricted Stock Units vest on May 7, 2027; however, the Reporting Person has elected to defer receipt of the shares until May 7, 2031.

Walgreens Boots Alliance, Inc.

Report date November 01, 2020 · Filed November 02, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	103,076	Last balance in matching sequence After 2020-11-01 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2020-11-01 · Grant · Acquired 11,111 · Balance 103,950 F1: Restricted stock unit award granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests in one-third increments on each of the first, second and third anniversaries of the November 1, 2020 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan. F2: Includes shares underlying restricted stock units issued in lieu of dividends (through October 31, 2020) on outstanding restricted stock units. Row 2 · 2020-11-01 · Tax withholding · Disposed 874 · Balance 103,076 F3: Disposition relating to the satisfaction of tax withholding obligations upon the vesting of restricted stock unit award granted in accordance with Rule 16b-3. F2: Includes shares underlying restricted stock units issued in lieu of dividends (through October 31, 2020) on outstanding restricted stock units.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.04 · Expires 2030-11-01	Direct	55,693	Reported balance After 2020-11-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-11-01 · Grant · Acquired 55,693 · Balance 55,693 F4: The option vests with respect to 18,545 shares on November 1, 2021, with respect to 18,546 shares on November 1, 2022, and with respect to 18,602 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related grant agreement thereunder).
Common StockSEC Table I · non-derivative	IndirectBy spouse IRA	250	Reported balance Holding disclosure · report date 2020-11-01 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 250

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock unit award granted under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related award agreement and the applicable election forms thereunder, the "Plan") vests in one-third increments on each of the first, second and third anniversaries of the November 1, 2020 date of grant, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Plan.

F2: Includes shares underlying restricted stock units issued in lieu of dividends (through October 31, 2020) on outstanding restricted stock units.

F3: Disposition relating to the satisfaction of tax withholding obligations upon the vesting of restricted stock unit award granted in accordance with Rule 16b-3.

F4: The option vests with respect to 18,545 shares on November 1, 2021, with respect to 18,546 shares on November 1, 2022, and with respect to 18,602 shares on November 1, 2023, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan (together with the related grant agreement thereunder).

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 19, 2017 Filed Jul 21, 2017 14:52 UTC	ASHLAND INC. ASH · Entity 4139	GrantRestricted Stock Units · Derivative	823	$66.88	$55,042.24	Disclosure SEC source: 0001127602-17-023971 · form4.xml · derivative · entry 2 Wilson-Thompson Kathleen · CIK 0001331680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823 Underlying: Common Stock · 823 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F4 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F4 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) Read SEC document
July 19, 2017 Filed Jul 21, 2017 14:52 UTC	ASHLAND INC. ASH · Entity 4139	GrantCommon Stock	1,883	$66.88	$125,935.04	Disclosure SEC source: 0001127602-17-023971 · form4.xml · nonDerivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 F1 · kind: Grant of Restricted Common Stock, pursuant to Ashland's Incentive Plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on the earlier of (i) the Outside Director's Retirement, as defined in the Plan; (ii) the Outside Director's death or Disability, as defined in the Plan; or (iii) a 50% change in the beneficial ownership of Ashland Global Holdings Inc. as defined in Rule 13d-3 under the Securities Exchange Act of 1934. F2 · balance_after: Balance includes 1,883 shares of unvested Restricted Stock. Read SEC document
June 15, 2017 Filed Jun 19, 2017 22:08 UTC	Vulcan Materials CO VMC · Entity 3118	GrantDeferred Stock Units · Derivative	1,160	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-17-011496 · doc4.xml · derivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,507.935 Underlying: Common Stock · 1,160 shares Expires not disclosed F1 · derivative.exercise_price: Convertible on a 1-for-1 basis. F2 · kind: Annual deferred stock grant made to the reporting person under the Vulcan Materials Company 2016 Omnibus Long-Term Incentive Plan. F3 · price: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan. F3 · derivative.exercise_date: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan. F3 · derivative.expiration_date: Deferred Stock Units are fully vested as of the grant date. Vested shares will be delivered to the reporting person in the month of April following the year in which the reporting person ceases to be a member of the Board of Directors, unless the reporting person has elected to defer payment of the award, or unless payment is made earlier due to the death or disability of the reporting person or a change in control of Vulcan. Read SEC document
November 28, 2016 Filed Nov 29, 2016 18:36 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,700	$0.00 Strike: $35.50	$0.00	Disclosure SEC source: 0001618921-16-000091 · edgar.xml · derivative · entry 4 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,700 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
November 28, 2016 Filed Nov 29, 2016 18:36 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	SaleCommon Stock	5,700	$85.05	$484,785.00	Disclosure SEC source: 0001618921-16-000091 · edgar.xml · nonDerivative · entry 2 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,251 F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through November 20, 2016) on outstanding restricted stock units. Read SEC document
November 28, 2016 Filed Nov 29, 2016 18:36 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionCommon Stock	5,700	$35.50	$202,350.00	Disclosure SEC source: 0001618921-16-000091 · edgar.xml · nonDerivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through November 20, 2016) on outstanding restricted stock units. Read SEC document
November 01, 2016 Filed Nov 2, 2016 16:55 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	GrantEmployee Stock Option (right to buy) · Derivative	60,738	$0.00 Strike: $82.46	$0.00	Disclosure SEC source: 0001618921-16-000078 · edgar.xml · derivative · entry 3 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,738 Underlying: Common Stock · 60,738 shares Expires 2026-11-01 F3 · derivative.exercise_date: The option vests on November 1, 2019, subject to acceleration or forfeiture in certain circumstances in accordance with the terms and conditions of the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (together with the related agreement thereunder). Read SEC document
November 01, 2016 Filed Nov 2, 2016 16:55 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Tax withholdingCommon Stock	3,824	$82.46	$315,327.04	Disclosure SEC source: 0001618921-16-000078 · edgar.xml · nonDerivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,184 F1 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of restricted stock unit award granted in accordance with Rule 16b-3. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2016) on outstanding restricted stock units. Read SEC document
October 21, 2016 Filed Oct 24, 2016 18:16 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Tax withholdingCommon Stock	5,445	$81.57	$444,148.65	Disclosure SEC source: 0001618921-16-000057 · edgar.xml · nonDerivative · entry 2 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,008 F2 · kind: Disposition relating to the satisfaction of tax withholding obligations upon the settlement of award granted in accordance with Rule 16b-3. F3 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2016) on outstanding restricted stock units. Read SEC document
October 21, 2016 Filed Oct 24, 2016 18:16 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	GrantCommon Stock	11,914	$0.00	$0.00	Disclosure SEC source: 0001618921-16-000057 · edgar.xml · nonDerivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,453 F1 · kind: Shares issued upon settlement of peformance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2013 under the 2013 Omnibus Incentive Plan, as amended. F3 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through September 30, 2016) on outstanding restricted stock units. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	13,200	$0.00 Strike: $35.50	$0.00	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · derivative · entry 7 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Underlying: Common Stock · 13,200 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	10,796	$0.00 Strike: $35.65	$0.00	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · derivative · entry 6 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,796 shares Expires 2021-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	SaleCommon Stock	13,200	$85.00	$1,122,000.00	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · nonDerivative · entry 4 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,539 F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.01, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through August 31, 2016) on outstanding restricted stock units. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionCommon Stock	13,200	$35.50	$468,600.00	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · nonDerivative · entry 3 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through August 31, 2016) on outstanding restricted stock units. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	SaleCommon Stock	10,796	$85.00	$917,660.00	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · nonDerivative · entry 2 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,539 F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through August 31, 2016) on outstanding restricted stock units. Read SEC document
September 08, 2016 Filed Sep 12, 2016 17:18 UTC	Walgreens Boots Alliance, Inc. WBA · Entity 16467	Exercise / conversionCommon Stock	10,796	$35.65	$384,877.40	Disclosure SEC source: 0001618921-16-000048 · edgar.xml · nonDerivative · entry 1 Wilson-Thompson Kathleen · CIK 0001331680 · EVP and Global Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transactions effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · balance_after: Includes shares underlying restricted stock units issued in lieu of dividends (through August 31, 2016) on outstanding restricted stock units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.